3E Company and The Redstone Group Partner to Help Companies Achieve REACH Compliance
03-26-2008: 3E Company(R) and The Redstone Group, LLC announced a non-exclusive partnership aimed at helping companies comply with Europe's Registration, Evaluation and Authorization of Chemicals (REACH) regulatory framework for chemical substances. As a result of the collaboration, 3E Company and The Redstone Group will be able to offer customers an expanded suite of REACH-related products and services.
"Over the past several months, we have noticed strong client and market demand for high quality professional services to facilitate compliance with REACH requirements," said Robert S. Christie, CEO and president, 3E Company. "In partnering with The Redstone Group, we will be able to provide our customers with the most comprehensive REACH solutions and services available today."
"REACH will fundamentally change the way chemicals are managed in Europe and possibly the rest of the world," said Glenn W. Hammer, founding principal, The Redstone Group. "Partnering with 3E Company helps us to offer our customers a comprehensive array of services for achieving REACH compliance."
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2SCHOTT Instruments has changed its name to SI Analytics
- 3VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
- 4SGS Minerals Services opens new lab in Chennai, India
- 5MDS Sciex Opens Manufacturing Facility in Singapore
- 6Sartorius opens new plant in India
- 7Affymetrix and eBioscience Amend Definitive Merger Agreement
- 8Fluidigm China Opens Its Doors
- 9Thermo Fisher Scientific Acquires NanoDrop Technologies
- 10PIAB announces new Chief Executive Officer
- Agilent Technologies and Universiti Putra Malaysia to Collaborate on Halal F ...
- Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella
- Malvern Instruments and Postnova Analytics co-operate to deliver combined so ...
- Analytik Jena and SOTAX announce cooperation in dissolution systems
- Sartorius Stedim Biotech and Refine Technology Announce Cooperation
- R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 -
- Predictive genetic test for bowel cancer treatment is introduced in the UK - - Amgen and Lab21 in Partnership Agreement for New Cancer Therapy Test
- Researchers use light to detect Alzheimer's - - New technique may help identify ways to predict and prevent deadly disease
- OncoMethylome Sciences Collaborators Identify Methylation Markers that are Associated with Lung Cancer Recurrence -
- PolyIC, BASF, Evonik Industries, Elantas Beck and Siemens form alliance project for printed electronics - - Radio frequency identification tags: the next generation





